Summary: Microvascular integrity is lost during focal cere bral ischemia. The degradation of the basal lamina and extra cellular matrix are, in part, responsible for the loss of vascular integrity. Matrix metalloproteinases (MMPs) may play a pri mary role in basal lamina degradation. By using a sensitive modification of gelatin zymography, the authors investigated the activity of MMP-2 and MMP-9 in frozen lO-f.Lm sections of ischemic and nonischemic basal ganglia and plasma samples of 27 non-human primates after middle cerebral artery occlusion/ reperfusion (MCAO/R) for various periods. The gelatinolytic activities were compared with parallel cell dUTP incorporation in the ischemic zones of adjacent sections. In the brain, the integrated density of MMP-2 increased significantly by 1 hour 
after MCAO and was persistently elevated thereafter. Matrix metalJoproteinase-2 expression was highly correlated with the extent of neuron injury and the number of injured neurons (r = 0.9763, SE = 0.004, 2P < 0.0008). Matrix metalloproteinase-9 expression only was significantly increased in subjects with hemor rhagic transformation. In plasma, only MMP-9 increased transiently at 2 hours of MCAO. These findings highlight the early potential role of MMP-2 in the degradation of basal lamina leading to neuronal injury, and an association of MMP-9 with hemorrhagic transformation after focal cerebral ischemia. Key Words: Matrix metalloproteinase-Cerebral ischemia-Zymography-Neuron injury-Hemorrhagic trans formation-Basal lamina.
ECM. The cerebral capillary wall contains type IV col lagen, laminins, and fibronectin as the major basal lamina components, in addition to entactin, thrombo spondin, nidogen, and heparan sulfates (Webersinke et a!., 1992) . The major components decrease roughly in parallel during experimental middle cerebral artery oc clusion and reperfusion (MCAOIR) . Loss of basal lamina integrity has been postulated to be the primary cause of microvascular hemorrhage during focal cerebral ischemia (Hamann et aI., 1996; Okada et aI., 1994) ,
The mechanisms responsible for basal lamina degra dation after MCAO/R are not yet defined. Noncellular proteolytic systems, including plasmin, certain serine proteases, matrix metalloproteinases (MMP), and prote ases secreted by activated polymorphonuclear (PMN) leukocytes, such as collagenase, gelatinase, elastase, and cathepsin-G, hydrolyze components of the basal lamina.
The MMPs, Zn 2 + endopeptidases that are secreted in la tent form, require activation for proteolytic activity and are inhibited by specific tissue inhibitors of metallopro teinase (TIMPs) (Nagase, 1997) . Matrix metalloprotein ase-2 (gelatinase A, 72-kDa type IV collagenase) and MMP-9 (gelatinase B, 92-kDa type IV collagenase), which degrade type IV collagen and the laminins, have been implicated in the physiologic conditions of differ-entiation, ECM and tissue remodeling, and wound heal ing. In the inflammatory and invasive conditions of tu mor metastasis and osteoarthritis, MMPs are involved when matrix alterations are central features (Aumailley, 1995) . In the central nervous system, changes in MMP-2 or MMP-9 expression have been associated with brain tumor growth (Rao et aI., 1993; Nakagawa et aI., 1994) , multiple sclerosis (Cuzner et aI., 1996; Maeda and Sobel, 1996 ; Anthony et aI., 1997), Alzheimer's disease (Peress et aI., 1995) , and amyotrophic lateral sclerosis (Lim et aI., 1996) .
Considering the distribution of ECM in the central nervous system, and the known venues of MMP-2 and MMP-9 activity, their contribution to brain tissue injury during ischemic stroke is likely to involve the microvas culature. In one recent study, MMP-9 was increased by 7 days in association with leukocyte invasion in the injury zone of patients who died shortly after stroke (Anthony et aI., 1997) . Rosenberg et al. (1996) demonstrated in creased MMP-2 and MMP-9 activity during MCAO in Wistar-Kyoto rats and spontaneously hypertensive rats (SHR). Furthermore, experiments using large concentra tions of bacterial collagenase (type VII, Sigma, St. Louis, MO, U.S.A.) suggest that MMP-9 may contribute to brain edema and hemorrhage subsequent to the disrup tion of the basal lamina (Rosenberg et aI., 1990) . The late appearance of MMP-2 and MMP-9 and the need for substantial exogenous MMP in those experiments are, thus far, inconsistent with the development of much ear lier neuron, microvascular, and glial injury. In contrast, the disruption of normal cell-matrix adhesion may in duce cell death (Frisch and Francis, 1994) , edema (Rosenberg and Navratil, 1997) , and loss of cell viability eRe et aI., 1994), as demonstrated when adhesion of hu man endothelial cells to ECM is inhibited. Those find ings suggest the possibility that endothelial cell, astro cyte, and neuron injury could follow from degradation of the microvascular basal lamina, and that mechanisms that contribute to early disruption of cell-matrix integrity may accentuate neuron injury. It would first be necessary to show that MMP secretion is enhanced after MCAO in concert with neuron injury.
In the present study, using a sensitive modification of gelatin zymography, we demonstrate rapid and signifi cant increases in MMP-2 and MMP-9 content in the ischemic basal ganglia very early after MCAO in the awake non-human primate, in parallel with evidence of neuron injury. The hypothesis tested in this study is that the upregulation of MMP-2 or MMP-9 is related to neu ron injury and to hemorrhagic transformation.
MATERIALS AND METHODS
The procedures used in this study were approved by the institutional Animal Research Committee and were performed according to standards published by the National Research Council (The Guide for the Care and Use of Laboratory Ani mals) and the U.S. Department of Agriculture Animal Welfare Act. Every effort was made to ensure that the subjects were free of pain and discomfort. All procedures were attended by the veterinarians, the primate handling staff, and principal investi gator.
Experimental stroke model in the non-human primate Cerebral tissues from adolescent male baboons (Papio anubis!cynocephalus) were used for these studies. All animals were neurologically normal before MCAO and apparently free of infections or inflammation during the experiments. The ex perimental approaches to the awake MCAO/R stroke model have been detailed in previous studies of this group (del Zoppo et aI., 1986; Hamann et aI., 1995) . All animals were allowed a 7-day procedure-free interval after surgical implantation of the balloon device before entry into the experiment. The experi mental procedure required inflation of the MCA balloon for I hour or 2 hours, or for 3 hours with various periods of subse quent MCA reperfusion. Seventeen subjects underwent MCAO for I hour (n = 3) or 2 hours (n = 6), or 3 hours MCAO with subsequent reperfusion for 1 hour (n = 3), 4 hours (n = 2), or 24 hours (n = 3). In addition, a control group (n = 5) did not undergo any preparation procedure, and a group of subjects (n = 5) that suffered 1enticulostriatal injury at surgical implanta tion were harvested 7 days later. An additional single sham operated subject underwent the implantation procedure and the 7-day recovery period, but did not undergo MCAO.
Tissue processing
Tissues were removed from the animals during sodium thio pental anesthesia by left ventricular transcardiac perfusion of the cranial structures at 180 to 200 mm Hg with chilled (4 DC) perfusate containing heparin (200 lUlL), nitroprusside (6.7 fLmoIlL), and bovine serum albumin (50 gIL; Sigma). Cranial tissues were removed en bloc within 15 minutes of complete perfusion and subdivided in I-cm coronal slices. From each slice, symmetrically located blocks (1 . 0 x 1.0 x 0.2 to 0.5 cm) of the basal gangl ia were cut and embedded in Tissue-Tek OCT compound (Miles, Inc., Elkhart, IN, U.S.A.), frozen in 2-meth ylbutane and dry ice, and stored at -80DC until sectioning.
Blood sampling and preparation
Blood samples were drawn from a peripheral vein into plain, EDT A, and heparinized tubes before surgical implantation, be fore MCAO, serially during MCAO, and during reperfusion. The total white cell count, white cell differential count, platelet count, and hematocrit were determined on commercial whole blood analyzers. Plasma was isolated from blood in EDTA and heparinized tubes, by centrifugation at 3,000 rpm for 15 min utes, and stored at -80°C until analysis.
Preparation of samples for zymography
For zymography, heparinized plasmas from eight subjects at baseline (before MCAO) and 2 hours of MCAO were analyzed together with plasmas from other times (3 hours of MCAO with 1, 3, and 24 hours reperfusion). Separately, consecutive lO-fLl11 cryostat sections from the ischemic and nonischemic basal gan glia were minced and dissolved in 120 fLL of homogenizing buffer (50 mmollL Tris-Hcl [pH 7.5], 75 mmollL NaCI, 1 mmollL phenyl methyl sulfonyl fluoride [PMSF; Sigma)). The homogenate was centrifuged at 4°C for 20 minutes at 9,000 rpm. Supernatants were divided into aliquots and stored at -80°C until analyzed. The protein concentration of each sample was measured with the Bio-Rad protein assay kit based on the method of Bradford (Bio-Rad Laboratories. Hercules. CA, U.S.A.) using a bovine gamma globulin standard.
Gelatin zymography
Gelatin zymography was performed based on methods modi fied from those previously published (Hibbs et aI., 1985; Kleiner and Stetler-Stevenson, 1994; Nakagawa et aI., 1994 pg recombinant human MMP-2 and MMP-9, which were di luted in collagenase buffer and mixed with equal volumes of sample buffer, were loaded on each gel. For electrophoresis, 8% SDS-polyacrylamide resolving gels containing I mg/mL gelatin were overlaid with 5% stacking gels, and samples we . re loaded and run at 4°C (25 mA per gel) . After electrophoresIs, gels were rinsed with distilled water briefly and washed three times in 150 mL 2.5% Triton X-100 solution (15 minutes each) on a rotary shaker. The gels were then incubated in 250 mL of 50 mmollL Tris-HCl (pH 7.5) containing 10 mmollL CaCI2 and 0.02% NaN3 at 37°C for 42 hours. In separate experiments, 10 mmol/L EDTA, 5 mmollL 1,1 O-phenanthroline (Sigma), 2 mmollL PMSF. or 1 f.LmollL trans-epoxysuccinyl-L leucylamido-( 4-guanidino)butane (E-3132; Sigma) was added to the incubation buffer to confirm the nature of the gelatino lytic activity. After incubation, gels were stained in 150 mL of 0.1 % amido black in acetic acid, methanol, and distilled water (1 :3:6 vol/vol/vol) for 60 minutes. The gels were then destained in 150 mL of the same solution without amido black for 130 minutes with four changes. After destaining, gels were im mersed in distilled water for 20 minutes, and scanned imme diately. The gelatinolytic activity was demonstrated as clear zones.
Scanning of gels and quantitation of gelatinolytic bands
Gels were scanned using a Personal Densitometer SI (Mo lecular Dynamics Inc., Sunnyvale, CA, U.S.A.) and quantified by the NIH Image 1.6 I Program staged on a Macintosh plat form. Each gel was scanned with a step tablet (Kodak Scanner
Step Tablet, ST-34; Eastern Kodak Co., Rochester, NY, U.S.A.) under the mode of 12 bits per pixel digital resolution and 100-f.Lm pixel size, after calibration. This mode provides 4,096 levels of digital resolution and 1,000 data points/cm 2 .
The band intensities were determined as described in the manual of the NIH Image Program. Briefly, the software was calibrated each time for each gel using the simultaneously scanned step tablet and linearized. After calibration, each band was curved using the gel-plotting macros. The measured value of the height of the curve at any point is the mean of the optical densities of a given row of pixels in the marked line and is expressed as the integrated density. Intragel reproducibility for protein extracts and plasmas was acceptable, and coefficients of variance of 4,8% ± 3.3% (n = 4; range, 0.48% to approximately 10.7%) were obtained. Stan dardization of electrophoresis running times and staining and destaining procedures was made to insure intergel reproduci bility. The intergel reproducibility of 50 pg recombinant human MMP-2 and MMP-9 standards was satisfactory, providing co efficients of variance of 13.9% and 12.6%, respectively (n = 10).
Normalization of integrated densities was performed by di viding values obtained from each sample by the fraction of recombinant human MMP-2 and MMP-9 standards run in par allel in the same gel.
dUTP incorporation and determination of the region of dUTP-incorporation
Evidence of nuclear DNA scission and repair was taken as an indication of significant cellular injury as previously described (Tagaya et aI., 1997) . Incorporation of digoxigenin-dUTP on lO-f.Lm cryosections was detected by the DNA polymerase I based procedure (Tagaya et aI., 1997) . Cryosections adjacent to those used for zymography were fixed with 10% neutral buffered formalin. After washing, sections were treated with 2% H202 for 5 minutes and incubated with 0. 1 U/f.LL DNA polymerase I (Promega, Madison, WI, U.S.A.) and digoxigenin DNA labeling mixture (Boehringer Mannheim Corp., India napolis, IN, U.S.A.) in translation buffer (50 mmollL Tris-HCI [pH 7.5], 10 mmollL MgS04, 50 j,Lg/mL bovine serum albu min) at 37°C for 60 minutes. After washing with phosphate buffered saline, the sections were incubated with horseradish peroxidase-conjugated antidigoxigenin antibody (Boehringer Mannheim Corp.) for 30 minutes. After further washing with phosphate-buffered saline, color was developed with 3-amino-9-ethyl carbazole (AEC kit, Biomeda Corp., Foster City, CA, U.S.A.). The extent of regions of dUTP incorporation (Ic) was marked on the slides by an investigator not involved in these 92 kDa--'
Gelatinolytic activities in protein extracts from frozen 10-!Jm sections of basal ganglia. Representative zymograins of non ischemic (l) and ischemic (R) basal ganglia from three subjects each undergoing 2 hours of MCAO (8) and 7 days of MCAO (C), compared with three control subjects (A), are shown. la nd R in control subjects (A) represent left and right basal ganglia, respec tively, which correspond to non ischemic and ischemic basal gan glia of those undergoing MCAO. Control subjects displayed only one band, just below the 72-kDa marker band of recombinant human MMP-2. All subjects undergoing MCAO demonstrated in creased gelatinolytic activities of both MMP-2 (70 kDa) and MMP-9 (100 kDa). Faint bands below the 70-kDa band (arrow head) are recognized in the ischemic basal ganglia samples from subjects 4, 5, 6, 8, and 9. These bands were easily detected by the scanner, but are less apparent in reproduction. r-MMP rep resents the mixture of recombinant human MMP-2 and MMP-9.
studies, and the slides were scanned under the mode of 12 bits per pixel digital resolution and a 50-f..l, m pixel size. This mode provided satisfactory images of sections with 4,096 levels of digital resolution and 4,000 data points/cm 2 . The total section and Ic region surface areas were measured using the NIH Im age Program.
Statistical analysis
All data are presented as the mean ± SO. The Mann-Whitney U Test was used for comparison between hemorrhagic and nonhemorrhagic subjects. Associations between MMP (inte grated density) and ischemic injury or leukocyte counts were performed by means of linear regression. Jackknifed standard errors (SE) of reported correlation coefficients are provided for assessment of the precision of the estimated correlations. As in the past (Tagaya et aI., 1997; Wagner et aI., 1997) , for temporal studies data were subject to square root transformation (to induce approximate normality) to which analysis of variance with Bonferroni corrections for multiple comparisons was applied. Significance was set at 2P < 0.05.
RESULTS

MMP-2 and MMP·9 during focal cerebral ischemia
Gelatin zymographic studies of frozen lO-f.Lm sections from ischemic and nonischemic basal ganglia displayed clear evidence of MMP-2 and MMP-9 activity (Fig. 2) . Nonischemic and ischemic specimens in control subjects represent the left and right basal ganglia. respec tively. which correspond to non-ischemic and ischemic basal ganglia of subjects undergoing MCAO. Values are mean ± SD of the integrated densities. MCAO. middle cerebral artery occlusion; R. reperfusion. Comparisons between control and post-MCAO specimens.
* 2p = 0.04. t 2p = 0.001. :j: 2p = 0.21. § 2p = 0.11. Table 2 ). 
Relationship of MMP to ischemic injury
2500.-------------------------------,
Association of MMP with hemorrhagic transformation
At least one subject at each time, eight total (36.4%), demonstrated visible hemorrhagic transformation of the Ie region after MCAO (Fig. 5) . The integrated density of the latent form of MMP-9 was significantly increased in the ischemic basal ganglia of those subjects displaying hemorrhagic transformation (773.10 ± 873.57) compared with those without hemorrhagic transformation (187.52 ± 174.27; 2P = 0.013) (Fig. 6 ). MMP-9 activity in the contralateral nonischemic basal ganglia was not signifi- • 
MMP-2 and MMP-9 in plasma
The four MMP bands were identified in all plasma samples. Besides these, a band above 121 kDa (approxi mately 130 kDa), whose identity is uncertain, was seen in 60.0% (15 of 25) of the plasma samples (Fig. 7) . A complex of 100-kDa MMP-9 and neutrophil ge1atinase associated lipocalin is conceivable (Kjeldsen et aI., 1993) . Alternatively, the dimer of active MMP-2 (Vartio and Baumann, 1989) or a complex of MMP-9 and TIMP-l (Moll et a!., 1990 ) may contribute to this band.
The latent forms of MMP-2 and MMP-9 were found in the plasmas of all nonischemic control subjects, and did not differ substantially.
The surgical implantation procedure did not affect the presence of MMP-2 or MMP-9 in plasma. The integrated densities of latent MMP-2 before and after the surgical implantation (n = 6) were 1,704.99 ± 492.67 and 1,936.81 ± 469.53, and those of latent MMP-9 were 552.49 ± 295.59 and 583.62 ± 280.59, respectively. After MCAO, no change in the constitutive levels of latent MMP-2 in plasma was seen. However, the latent form of MMP-9 in the plasma increased transiently at 2 hours of MCAO (2P = 0.002), and decreased thereafter (Fig. 8) .
No relationship between the integrated density of plasma MMP-9 and the total peripheral blood leukocyte, PMN leukocyte, or monocyte counts was demonstrated.
For instance, the correlation between latent MMP-9 and PMN leukocyte count did not reach statistical signifi cance (r = 0.425, SE = 0.238, 2P = 0.079) (Fig. 9) .
Separately, plasma MMP-2 and MMP-9 levels did not show any association with hemorrhagic transformation. expression by most cell types (Yu et a!., 1996) . In con trast, MMP-9 was not increased in the nonischemic tis sues of control subjects. Matrix metalloproteinase-9 was Matrix metalioproteinase-9 activity was transiently increased at 2 hours of MCAO, whereas MMP-2 did not change.
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-'iii 400 1994). Although this study does not locate the cellular source of MMP-2 and MMP-9 activities in primate brain, both MMP have been identified with endothelial cells (Nakagawa et a!., 1994; Cuzner et a!., 1996; Maeda and Sobel, 1996) , astrocytes (Cuzner et aI., 1996) , and mi croglia (Cuzner et a!., 1996; Maeda and Sobel, 1996) .
The endogenous expression of MMP is regulated at sev eral levels. At the transcriptional level, the synthesis of MMP-9 is upregulated by cytokines including interleu kin-l � and tumor necrosis factor-a (Unemori et aI., 1991; Hanemaaijer et aI., 1993) , whose mRNA are de tected as early as 1 hour after MCAO in rats (Liu et a!., 1993 ). An AP-l promoter site, to which the prod ucts of immediate early genes bind, appears to cooperate with SPl , PEA3, and nuclear factor-KB sites to induce MMP-9 transcription (Gum et a!., 1996) . Although the promoter sites of MMP-2 are not fully characterized, a recent report describes an AP-l site on the MMP-2 gene (Bian and Sun, 1997) . However, the exact transcriptional mechanisms remain to be illuminated. Rosenberg et a!. (1996) first reported increases in MMP-9 activity by 12 to 24 hours and MMP-2 activity by 5 days after permanent MCAO in anesthetized Wistar-Kyoto rats and SHR. The significantly earlier in crease in MMP-2 in the non-human primate basal gan glia may have been related in part to the more sensitive zymographic assay used here, species differences in the models used, and ancillary effects including the impact of anesthetics in the rodent studies. demonstrated marked temporal and topographic differ ences in cellular injury after MCAO, displayed by nuclear incorporation of dUTP, between non-human pri mates and Wistar rats. In addition to species differences, anesthetics, including barbiturates, have been demon strated to reduce cerebral injury after focal and global ischemia, whereas halogenated anesthetics significantly impair leukocyte chemotaxis in humans and primates, potentially delaying the inflammatory cell contribution to the infarct (Ember et aI., 1994) .
A very significant linear relationship between the in crease in latent MMP-2 activity and the volume of dUTP incorporation (Ie region) throughout MCAO/R implies a potential direct relationship between MMP-2 activity and cell injury after MCAO in the primate. This relationship was strongest at 2 hours of MCAO, when 80% ± 6.6% of cells that incorporate dUTP are neurons in this model (Tagaya et aI., 1997) . Here, early MMP-2 secretion may result in or be related to early neuron injury. An intact basal lamina matrix and integrin-mediated matrix adhe sion are required for cell survival, so that disruption of cell and matrix contacts may lead to changes in cell viability (Frisch and Francis, 1994; Re et aI., 1994) . Al though yet unproven for the cerebral microvasculature, alterations in endothelial cell and astrocyte endfoot pro cesses that occur in the time of increased MMP-2 ex pression and evident neuron injury may result from loss of those matrix contacts. Astrocytes suffer cytoplasmic alterations, and swelling of the endfeet occur very early after MCAO (Garcia et aI., 1993) . We have shown that integrins Ul131 on endothelium (Tagaya et aI., unpub lished data) and u6134 on astrocytes (Wagner et aI., 1997) are lost at the same time as their ligands within the basal lamina (Hamann et aI., 1995) . One of the notable findings in the present study is the significant increase of latent MMP-9 in subjects with hemorrhagic transformation. Hemorrhagic transforma tion develops as a consequence of evolving ischemic injury and is associated with the use of plasminogen activators in cerebral ischemia (del Zoppo et a!., 1990 (del Zoppo et a!., , 1998 . Okada et aI. (1994) and Hamann et aI. (1996) demonstrated that degradation of microvascular basal lamina during cerebral ischemia allows emigration of plasma components and hemoglobin in the non-human primate. Although the predisposing or triggering factors responsible for hemorrhagic transformation are not well understood, major alterations in vascular permeability and vessel wall integrity occur (Okada et aI., 1994; Hamann et aI., 1996; del Zoppo et aI., 1995) . On the basis of experiments with bacterial collagenase-induced intracerebral hemorrhage in rats, Rosenberg et a!. (1990) have suggested that MMP may cause brain edema and hemorrhage by breaking down vascular matrix and opening the blood-brain barrier. Our findings specifically im plicate early MMP-9 expression in hemorrhagic transfor mation. It is not possible to determine whether an in volvement of MMP-9 is causal or resultant to hemorrhage in the present experiments, however. Gen eration of thrombin during the hemorrhage may also stimulate MMP secretion from myointimal smooth muscle cells (Fabunmi et aI., 1996) and provide a stimu lus for the increases in MMP-9 levels. The absence of a parallel increase in MMP-9 levels from nonischemic tis sue rules out an increased risk of hemorrhage on the basis of a genetic predisposition. A causative involvement of MMP-9 in these events remains to be tested. (Hibbs et aI., 1985; Kjeldsen et aI., 1992; Vartio and Baumann, 1989) and increase early during MCAO in this model (Ember et a!., 1994) , no clear correlation between MMP-9 activity and leukocyte count could be seen here.
This lack of correlation also has been noted in human plasma (Kjeldsen et aI., 1992) . Significant interindivid ual differences in leukocyte MMP-9 content or differ ences in leukocyte activation are possible explanations (Kjeldsen et aI., 1992) . Removal of activated leukocytes from the circulation or decreases in cell responsiveness after MCAO in this model may be alternative explana tions (Ember et aI., 1994) . The possibility that a modest contribution of MMP-9 from activated PMN leukocytes to MMP-9 activity in the ischemic Ie region cannot be excluded.
In this study, the inactive forms of MMP-2 and MMP-9 and the active form of MMP-2 were increased in ischemic brain. The inactive forms of MMP-2 and MMP-9 are secreted from cells into the extracellular space immediately after synthesis, and then activated by cleavage of their propeptides by specific proteases. Plas min plays a central role in the activation of MMP-9 (Murphy et aI., 1994; Nagase, 1997) , and membrane type MMPs activate pro-MMP-2 at cell surfaces (Sato et aI., 1996) . The presence of membrane-type MMP, known to activate pro-MMP-2 in the region of increased MMP-2 expression, may be taken as further evidence that the increased latent MMP-2 is locally activated. The activation of latent MMP-2 and MMP-9 and their final enzymatic reactions are regulated by TlMP. Tissue in hibitor of metalloproteinase-2 is an inhibitor of MMP-2 (Stetler-Stevenson et aI., 1989), whereas TlMP-1 inhibits most MMP including MMP-9 (Woessner, 199 1) . In one report, TlMP-l mRNA was induced at 12 hours and reached a peak level at 2 days after prolonged and tran sient MCAO in the SHR (Wang et aI., 1998 ). However,
J. H. HEO ET AL.
the simultaneous quantitation of MMP and TIMP levels in tissue is problematic. In this study, the active forms of MMP-2 and MMP-9 in the ischemic tissues were rela tively absent. This pattern of latent MMP-related activity also has been described in cerebral ischemia in rats (Rosenberg et aI., 1996) and human stroke (Clark et aI., 1997) The very early appearance of MMP-2 in particular raises the novel proposal that disturbances of the matrix con tacts between endothelial cells and astrocytes may con tribute to neuron injury.
